Zhibao Technology Inc. (ZBAO) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

High Risk
Significant dilution risk
Last updated: April 23, 2026

Risk Assessment Details

Potential Dilution: 382.52% of current shares
Recent Dilution: 122.94% (2 years)
Historical Dilution Factor: significant recent dilution
Outstanding Shares
16M
Potential Supply
62M
Additional shares possible
Splits
None
Past 2 years

Summary

ZBAO currently has 16.2M outstanding shares. with significant dilution risk as 62.1M authorized shares could dilute existing holders by 382.5%. The company has significantly diluted shareholders by 122.94% over the past 2 years, indicating aggressive capital raising.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
Apr 23, 2026

F-1 filing: This F-1 filing outlines the details of Zhibao Technology Inc., a Cayman Islands-based InsurTech company operating in China, and its proposed offering of securities.

16M 62M
Sep 09, 2025

F-1 filing: This is an F-1 filing for Zhibao Technology Inc.

16M 62M
Mar 26, 2025

F-1 filing: This F-1 filing relates to the offering of Class A ordinary shares issuable upon conversion of a Second Tranche Note and the exercise of warrants by the Selling Shareholder.

15M 47M
Jan 10, 2025

F-1 filing: This F-1 filing relates to the offering of Class A ordinary shares of Zhibao Technology Inc. by selling shareholders, including shares issuable under the GEM Purchase Agreement and upon the exercise of various warrants. The company will not receive any proceeds from the resale of Class A ordinary shares, but will receive proceeds from any cash exercise of the Common Warrants.

32M 38M
Oct 31, 2024

20-F filing | 14.7M shares outstanding

15M 4.3M
Sep 30, 2024

F-1 filing: This F-1 filing relates to the offering of Class A ordinary shares of Zhibao Technology Inc. by a selling shareholder, including shares issuable upon conversion of a note, exercise of warrants, and exercise of pre-funded warrants. The company will not receive any proceeds from the resale of shares by the selling shareholder, except from the cash exercise of warrants, which will be used for working capital and general corporate purposes.

15M 4.3M
Sep 08, 2023

F-1 filing: This is an F-1 filing for an offering of ordinary shares underwritten by EF HUTTONdivision of Benchmark Investments, LLC.

N/A 0
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime